Abstract:Background: Delayed, large-volume bacterial culture and amotosalen/ultraviolet-A light pathogen reduction are effective at reducing the risk of bacterial proliferation in platelet concentrates (PCs). Hemovigilance programs continue to receive reports of suspected septic transfusion reactions, most with low imputability. Here, we compile national hemovigilance data to determine the relative efficacy of these interventions. Study design and methods: Annual reports from the United Kingdom, France, Switzerland, and Belgium were reviewed between 2005 and 2016 to assess the risk of bacterial contamination and septic reactions. Results: Approximately 1.65 million delayed, large-volume bacterial culture-screened PCs in the United Kingdom and 2.3 million amotosalen/ultraviolet-A-treated PCs worldwide were issued with no reported septic fatalities. One definite, one possible, and 12 undetermined/indeterminate septic reactions and eight contaminated "near misses" were reported with delayed, large-volume bacterial cultures between 2011 and 2016, for a lower false-negative culture rate than that in the previous 5 years (5.4 vs. 16.3 per million: odds ratio, 3.0; 95% confidence interval, 1.4-6.5). Together, the Belgian, Swiss, and French hemovigilance programs documented zero probable or definite/certain septic reactions with 609,290 amotosalen/ultraviolet-A-treated PCs (<1.6 per million). The rates were significantly lower than those reported with concurrently transfused, nonpathogen-reduced PCs in Belgium (<4.4 vs. 35.6 per million: odds ratio, 8.1; 95% confidence interval,1.1-353.3) and with historic septic reaction rates in Switzerland (<6.0 vs. 82.9 per million: odds ratio, 13.9; 95% confidence interval, 2.1-589.2), and the rates tended to be lower than those from concurrently transfused, nonpathogen-reduced PCs in France (<4.7 vs. 19.0 per million: odds ratio, 4.1; 95% confidence interval, 0.7-164.3). Conclusion: Pathogen reduction and bacterial culture both reduced the incidence of septic reactions, although under-reporting and strict imputability criteria resulted in an underestimation of risk.

Three Different Bacterial Detection Systems for Platelet Concentrates under Inter-Laboratory Conditions.

On the Tree Augmentation Problem

Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system

Detection of Bacterial Contamination of Apheresis Platelets in a Chinese Blood Center

Gram Stain-Specific-Probe-Based Real-Time PCR for Diagnosis and Discrimination of Bacterial Neonatal Sepsis

Gram-specific Probes Based Real-Time PCR Assay for Simultaneous Detection of Gram-positive and -Negative Bacterial Neonatal Sepsis

Feasibility of implementing an automated culture system for bacteria screening in platelets in the blood bank routine

Operational feasibility of routine bacterial monitoring of platelets

Routine bacterial screening of platelet concentrates by flow cytometry and its impact on product safety and supply

Detection of Bacterial DNA by PCR and Reverse Hybridization in the 16s Rrna Gene

Rapid Diagnosis of Bacterial Sepsis with PCR Amplification and Microarray Hybridization in 16S rRNA Gene

Bacterial Detection of Platelets: Current Problems and Possible Resolutions

Evaluation of the value of anaerobic culture in bacterial contamination forapheresis platelets

The use of a chemiluminescence‐linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell‐reduced and nonreduced platelets

Screening of platelets for bacterial contamination at the Welsh Blood Service

The international experience of bacterial screen testing of platelet components with automated microbial detection systems: An update

Adenosine and related compounds do not affect nerve terminal excitability in rat CNS

Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results

Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems

Bacterial contamination of platelets concentrates in a lower middle-income country: Data from a single tertiary care hospital

Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction